Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The BARCODE 1 Pilot Study: The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening

NCT03158922 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT03158922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03158922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The BARCODE 1 Pilot Study: The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Observational
Overall status
Active, not recruiting
Start date
April 29, 2016
Completion date
December 31, 2028
Enrollment
329 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer